Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 3, 2010, Pages 667-676

  Fitzpatrick III, J Raymond ^a   Frederick, John R ^a   McCormick, Ryan C ^a   Harris, David A ^a   Kim, Ah Young ^a   Muenzer, Jeffrey R ^a   Gambogi, Alex J ^a   Liu, Jing Ping ^a   Paulson, E Carter ^a   Woo, Y Joseph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; FLUORESCEIN; LECTIN; MEMBRANE PROTEIN; SCATTER FACTOR; VASCULOTROPIN A; ANGIOGENIC PROTEIN; HGF PROTEIN, HUMAN; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EXPERIMENTAL ANIMAL; EXPERIMENTAL RAT; FIBROBLAST; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEWIS RAT; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; CELL SURVIVAL; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEMODYNAMICS; METABOLISM; MICROCIRCULATION; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; TIME; TISSUE SCAFFOLD; TRANSPLANTATION;

ANGIOGENIC PROTEINS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROBLASTS; HEMODYNAMICS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77955985193     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.12.037     Document Type: Article

References (35)

1. M. Prech, S. Grajek, A. Marszalek, M. Lesiak, M. Jemielity, and A. Araszkiewicz Chronic infarct-related artery occlusion is associated with a reduction in capillary density. Effects on infarct healing Eur J Heart Fail 8 2006 373 380
2. C.E. Rochitte, J.A. Lima, D.A. Bluemke, S.B. Reeder, E.R. McVeigh, and T. Furuta Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction Circulation 98 1998 1006 1014
3. L. Bolognese, N. Carrabba, G. Parodi, G.M. Santoro, P. Buonamici, and G. Cerisano Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction Circulation 109 2004 1121 1126
4. C. Heilmann, C. Kostic, B. Giannone, A.B. Grawitz, W. Armbruster, and G. Lutter Improvement of contractility accompanies angiogenesis rather than arteriogenesis in chronic myocardial ischemia Vascul Pharmacol 44 2006 326 332
5. P.I. McConnell, C.L. Del Rio, D.B. Jacoby, M. Pavlicova, P. Kwiatkowski, and A. Zawadzka Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure J Thorac Cardiovasc Surg 130 2005 1001 1009
6. J.J. Gavira, J. Herreros, A. Perez, M.J. Garcia-Velloso, J. Barba, and F. Martin-Herrero Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up J Thorac Cardiovasc Surg 131 2006 799 804
7. H.C. Ott, J. Brechtken, C. Swingen, T.M. Feldberg, T.S. Matthiesen, and S.A. Barnes Robotic minimally invasive cell transplantation for heart failure J Thorac Cardiovasc Surg 132 2006 170 173
8. J.F. Symes, D.W. Losordo, P.R. Vale, K.G. Lathi, D.D. Esakof, and M. Mayskiy Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease Ann Thorac Surg 68 1999 830 836
9. T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, and M. Simons Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease Am Heart J 142 2001 872 880
10. J. Rutanen, T.T. Rissanen, J.E. Markkanen, M. Gruchala, P. Silvennoinen, and A. Kivelä Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 109 2004 1029 1035
11. V. Jayasankar, Y.J. Woo, T.J. Pirolli, L.T. Bish, M.F. Berry, and J. Burdick Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure J Card Surg 20 2005 93 101
12. W. Wang, Z.J. Yang, D.C. Ma, L.S. Wang, S.L. Xu, and Y.R. Zhang Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer Acta Pharmacol Sin 27 2006 555 560
13. Y. Guo, J. He, J. Wu, L. Yang, S. Dai, and X. Tan Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis Arch Med Res 39 2008 179 188
14. R.J. Laham, L. Garcia, D.S. Baim, M. Post, and M. Simons Therapeutic angiogenesis using basic fibroblast growth factor and vascular endothelial growth factor using various delivery strategies Curr Interv Cardiol Rep 1 1999 228 233
15. Y. Seow, and M.J. Wood Biological gene delivery vehicles: beyond viral vectors Mol Ther 17 2009 767 777
16. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, and S.K. Dupras Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024
17. J. Dow, B.Z. Simkhovich, L. Kedes, and R.A. Kloner Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy Cardiovasc Res 67 2005 301 307
18. J. Muller-Ehmsen, P. Whittaker, R.A. Kloner, J.S. Dow, T. Sakoda, and T.I. Long Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium J Mol Cell Cardiol 34 2002 107 116
19. M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh, and C.E. Murry Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies J Mol Cell Cardiol 33 2001 907 921
20. I.A. Memon, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, and A. Taketani Repair of impaired myocardium by means of implantation of autologous myoblast sheets J Thorac Cardiovasc Surg 130 2005 1333 1341
21. H. Kondoh, Y. Sawa, S. Miyagawa, S. Sakakida-Kitagawa, I.A. Memon, and N. Kawaguchi Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters Cardiovasc Res 69 2006 466 475
22. W.A. Marston, J. Hanft, P. Norwood, R. Pollak for the Dermagraft Diabetic Foot Ulcer Study Group The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial Diabetes Care 26 2003 1701 1705
23. R.S. Kellar, L.K. Landeen, B.R. Shepherd, G.K. Naughton, A. Ratcliffe, and S.K. Williams Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue Circulation 104 2001 2063 2068
24. R.S. Kellar, B.R. Shepherd, D.F. Larson, G.K. Naughton, and S.K. Williams Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct Tissue Eng 11 2005 1678 1687
25. J.N. Mansbridge, K. Liu, R.E. Pinney, R. Patch, A. Ratcliffe, and G.K. Naughton Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers Diabetes Obes Metab 1 1999 265 279
26. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D.A. Kass Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats Nat Protoc 3 2008 1422 1434
27. Y.J. Woo, T.J. Grand, M.F. Berry, P. Atluri, M.A. Moise, and V.M. Hsu Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy J Thorac Cardiovasc Surg 130 2005 321 329
28. P. Atluri, G.P. Liao, C.M. Panlilio, V.M. Hsu, M.J. Leskowitz, and K.J. Morine Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy Ann Thorac Surg 81 2006 1728 1736
29. Y.H. Liu, X.P. Yang, O. Nass, H.N. Sabbah, E. Peterson, and O.A. Carretero Chronic heart failure induced by coronary artery ligation in Lewis inbred rats Am J Physiol 272 2 Pt 2 1997 H722 H727
30. M.S. Gee, W.N. Procopio, S. Makonnen, M.D. Feldman, N.M. Yeilding, and W.M. Lee Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy Am J Pathol 162 2003 183 193
31. L. Brown, A. Fenning, V. Chan, D. Loch, K. Wilson, and B. Anderson Echocardiographic assessment of cardiac structure and function in rats Heart Lung Circ 11 2002 167 173
32. P. Atluri, and Y.J. Woo Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential BioDrugs 22 2008 209 222
33. S. Ylä-Herttuala, T.T. Rissanen, I. Vajanto, and J. Hartikainen Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine J Am Coll Cardiol 49 2007 1015 1026
34. A. Beenken, and M. Mohammadi The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 2009 235 253
35. H.M. Thai, E. Juneman, J. Lancaster, T. Hagerty, R. Do, and L. Castellano Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction Cell Transplant 18 2009 283 295